???????????????????????? ???????????????????????????????????? ???????????????????????? ???????????????????????????? ????????????????: ???????????????????????????????????????? ???????????? ???????????????? ???????? ???????????????????????????????????????????? ????????????????????????????????
The global asthma treatment market has witnessed significant growth over the years and is poised for continued expansion in the foreseeable future. Valued at US$ 24.0 billion in 2021, the market is projected to achieve a compound annual growth rate (CAGR) of 3.7% from 2022 to 2031, reaching an impressive value of more than US$ 34.5 billion by the end of 2031. This growth trajectory is a testament to the increasing awareness about asthma treatment and the evolving landscape of respiratory care.
Request for a sample of this research report at (Use Corporate Mail Id for Quick Response) -
???????????????????????????? ???????????????????????????? ???????????? ???????????????????????? ????????????????????????????????
The surge in awareness initiatives surrounding asthma treatment is a pivotal driver for the market's growth. Organizations such as the Centers for Disease Control and Prevention's National Asthma Control Program have undertaken commendable efforts to raise awareness about asthma and its treatment options. Collaborative endeavors like asthma camps organized by the Asthma Society of India further contribute to market expansion.
The rising prevalence of asthma, coupled with the adoption of combination therapies and the emergence of smart inhaler technology, is fueling demand for effective asthma treatments. The pharmaceutical industry's focus on innovation and collaborations is also playing a vital role in driving market growth. Notable partnerships like AstraZeneca's collaboration with Avillion Company to develop the 'PT027' asthma rescue inhaler exemplify this trend.
???????????????????????????????????????????????????? ???????????????????????? ???????????? ???????????? ????????????????????????????????????
Asthma, characterized by the narrowing and swelling of airways, causes difficulties in breathing, accompanied by symptoms such as coughing, wheezing, and shortness of breath. While some experience only minor inconveniences, for others, asthma can disrupt daily life and even lead to life-threatening asthma attacks.
Several factors can exacerbate asthma symptoms, including exercise-induced asthma triggered by cold and dry air, as well as occupational asthma resulting from exposure to workplace irritants. Allergy-induced asthma is caused by allergens like pollen, mold spores, and pet dander.
Asthma treatment involves various options, including nebulizers and spacers, with nebulizers being preferred for their ability to deliver medication quickly and efficiently to patients.
???????????? ???????????????? ???????????????????????????? ???????????????????????????????? ???????????????????????? | ???????????????????????????????????? ???????????????????????????????? ???????????????????????????????????? ???????? -
???????????????????????? ???????????????????????????? ???????????????????????? ???????????? ???????????????????????????????????? ????????????????????????
Asthma is a significant global public health concern, affecting millions of individuals worldwide. Genetic and environmental factors contribute to its prevalence, with microbial exposure, passive smoking, and air pollution playing significant roles. In 2019, asthma impacted around 262 million people, resulting in approximately 455,000 fatalities, as per the World Health Organization (WHO). Underdiagnosis and undertreatment remain pressing issues, particularly in low- and lower-middle-income countries.
In the United States alone, nearly 26 million people suffer from asthma, with associated costs exceeding US$ 56 billion annually. This mounting disease burden underscores the need for effective asthma treatments.
???????????????? ???????? ???????????????????????????????????? ???????????? ????????????????????????????????????
A growing emphasis on asthma awareness is a prominent trend, with events like World Asthma Day and National Asthma and Allergy Awareness Month promoting knowledge about asthma attack treatment globally. Initiatives like the CDC's National Asthma Control Program and educational campaigns contribute to improved asthma management and patient outcomes.
???????????????????????????????????? ???????????????????????????????????????? ???????????? ???????????????????????? ????????????????????????????????????????????????
The asthma treatment market can be categorized into long-term asthma control medications and quick-relief (rescue) medications. Long-term control medications, including inhaled corticosteroids like ADVAIR DISKUS and Symbicort, dominate the market due to their efficacy.
In terms of administration routes, inhaled medications hold a significant share, as they offer direct absorption into the lung's epithelium. Retail pharmacies emerge as the primary distribution channel, aligning with the increase in asthma therapeutics dispensed through these outlets.
???????????????????????????? ???????????? ???????????????????????????????????????????????????? ???????? ???????????????? ???????????????????????????????? ???????????????????????? ???????? -
???????????????????????????????? ???????????????????????? ???????????? ???????????? ????????????????????????????
North America currently commands a substantial market share, driven by factors such as recent FDA approvals, robust drug pipelines, and initiatives to diagnose and treat asthma cases early. Asia Pacific is anticipated to exhibit rapid growth, fueled by high asthma prevalence, environmental pollution, and rising awareness.
Key players in the asthma treatment market include Mylan N.V., AstraZeneca plc, Boehringer Ingelheim, GlaxoSmithKline plc, Lupin Pharmaceuticals, and more. These players engage in product portfolio expansion and strategic partnerships to enhance their offerings and contribute to market growth.
???????????????? ???????????????????????????????? ???????????????????????????? ???????? ???????????????????????????????????????????????? ???????????????????????? ???????????????????????????????? -
Veterinary Molecular Diagnostics Market
Meningococcal Vaccines Market
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
